Cadila Healthcare Ltd. | CADILAHC | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary

Financial Summary Report of Cadila Healthcare Ltd.



CADILAHC
Cadila Healthcare Ltd.

Rs. 345.95
04-Mar-2022

5 Yr Performance

1 Yr Performance

Valuation



Quarterly Revenue, Net Income and Adjusted Share Price




Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.